Search - tctmd.com

Displaying 621 - 640 of 1354

Sort: Relevancy | Date

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 2

Todd Neale

June 07, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Shelley Wood

May 17, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Caitlin E. Cox

May 07, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2021

Caitlin E. Cox

May 03, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

Yael L. Maxwell

April 26, 2021

Advertisement

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

Statins Not Linked to Dementia or Memory Changes: ASPREE

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

COVID-19: TCTMD’s Daily Dispatch for June Week 2

June 2021 News Roundup

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Prediabetes Linked to Higher MACE Risk

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

TCTMD’s Top 10 Most Popular Stories for April 2021

FDA Approves Dapagliflozin for CKD Patients

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content